TCL Archive Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers April 25, 1980
TCL Archive New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials December 28, 2001
TCL Archive DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says May 31, 1991